On September 8, 2023, Edward Jordan informed Humanigen, Inc. of his resignation from his position as Chief Commercial Officer of the Company, effective September 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -83.33% |
Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Mar. 08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 23.82K | |
-2.00% | 89.22B | |
+1.32% | 40.49B | |
-15.73% | 32.79B | |
+64.13% | 26.23B | |
-21.28% | 14.52B | |
-8.50% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- HGEN.Q Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer